Restricted emergency use approvals to Covishield, Covaxin not granted in haste: SC

New Delhi |Tuesday, 2022 3:45:10 AM IST

The Supreme Court on Monday said the material provided by the Centre does not warrant the conclusion that restricted emergency use approvals were granted to Covishield and Covaxin in haste, without th

Read more

Covishield, Covaxin cleared for regular market approval

New Delhi |Thursday, 2022 5:15:07 AM IST

India's two main vaccines -- Bharat Biotechs Covaxin and Serum Institute of India's Covishield -- on Wednesday got the nod for regular market authorisation.

Read more

Serum Institute applies for full market authorisation of Covishield

New Delhi |Friday, 2021 9:15:08 PM IST

Pune-based Covid vaccines manufacturer Serum Institute has requested the Indian health ministry and Central Drugs Standard Control Organisation (CDSCO) for full market authorisation for its Covishield

Read more